Northwestern faculty, staff, students and alumni are stepping up in response to the global crisis that is the coronavirus pandemic.
From high-impact research, drug trials and innovative new projects, scientists are helping mitigate COVID-19. In our communities, experts and volunteers are pitching in, performing tasks large and small to help lift up neighbors and those in need. On campus, the fabric of the University community is being remade in the digital space so everyone can work, learn and laugh together in ways that feed the soul and sustain us all.
In recent news, Northwestern Medicine has launched a registry, seeking 5,000 volunteers, for a Phase 3 trial to investigate the new AstraZeneca vaccine drug candidate.
Northwestern researchers uncovered a new vulnerability in the novel coronavirus’ infamous spike protein — illuminating a relatively simple, potential treatment pathway.
And, epidemiologist Mercedes Carnethon testified recently before the U.S. Senate on how to mitigate the impact of COVID-19 on minority older adults.